Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Enzymes called PADIs play a key role in hair growth and loss.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Stress-related hair loss was reversed with a special medication.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Nerves and chemicals in the body can affect hair growth and loss.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.